New KDIGO updates push earlier IgA nephropathy treatment, targeting immune pathways and nephron protection to cut proteinuria and slow eGFR decline. In this episode, Integrating Risk Stratification ...
In this episode titled, Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical ...
Immunoglobulin A (IgA) deficiency is the most common primary immunodeficiency in humans. It can increase the risk of allergies, asthma, and autoimmune disease. Primary immunodeficiencies are ...
Immunoglobulin A (IgA) nephropathy, also called Berger disease, occurs when IgA antibodies clump, damage kidney filters, and cause blood and protein in the urine. Liver disease is the most common ...
IgA nephropathy can shorten life expectancy by 10 years on average. Life expectancy can depend on several factors, including kidney function at diagnosis, protein levels in the urine, age, other ...
Hosted on MSN
6 types of treatments for IgA nephropathy
IgA nephropathy (IgAN) is a kidney condition where antibodies (immune system proteins) build up and cause damage in your kidneys. IgAN, also known as Berger's disease, does not have a cure. However, ...
Dr Dana Rizk discusses Voyxact (sibeprenlimab-szsi), a new FDA-approved treatment to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results